We can go back and forth all day. I see it as a rhetorical question, the market is speculative as is MNTA or any other sub $250EV company I or anyone else lists as a potential best prospect investment.
If MNTA does get Copaxone approval and launch in 2012, then it would be a great 2012 play and I'm not sure I could come up with a better investment prospect for that time frame.
Market Data 
Markets 
AI
